Axim Biotechnologies, Inc. (AXIM): Revenue
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$39.5K
Year ended 2023-12-31
-27.4%
5-year compound annual growth
+6.2%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | $39.5K | +345.3% | 2024-04-16, From 2023-01-01 |
| 2022-12-31 | $8.9K | -85.3% | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | $60.5K | n/a | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | $0 | -100.0% | 2022-04-19, From 2020-01-01 |
| 2019-12-31 | $799.5K | +308.7% | 2020-05-20, From 2019-01-01 |
| 2018-12-31 | $195.6K | +311.2% | 2020-05-20, From 2018-01-01 |
| 2017-12-31 | $47.6K | +1.1% | 2019-04-08, From 2017-01-01 |
| 2016-12-31 | $47.1K | -4.2% | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | $49.1K | n/a | 2017-09-14, From 2015-01-01 |
| 2014-12-31 | $0 | -100.0% | 2016-04-18, From 2014-01-01 |
| 2013-12-31 | $21.7K | -50.0% | 2014-03-04, From 2013-01-01 |
| 2012-12-31 | $43.3K | +333.3% | 2014-03-04, From 2012-01-01 |
| 2011-12-31 | $10.0K | n/a | 2013-04-15, From 2011-01-01 |